[144] Stoke Therapeutics, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Stoke Therapeutics (STOK): An insider proposes to sell 61,885 common shares through Morgan Stanley Smith Barney with an approximate aggregate market value of $1,223,466.45. The filing reports 54,797,418 shares outstanding and an approximate sale date of 08/29/2025 on NASDAQ. Acquisition history shows 27,000 shares from exercised options on 05/25/2022 (paid in cash), 15,421 RSUs on 12/01/2024, and 19,464 PSUs on 12/03/2024. The filing also discloses a prior sale by Edward M. Kaye of 12,126 shares on 08/18/2025 for $221,153.99. Several filer identification fields in the header appear blank in the provided content.

Insights

Securities Analyst

TL;DR: Routine insider sale notice covering ~61.9k shares; size is small relative to outstanding shares and appears procedural.

The filing documents a planned sale via a major broker with clear acquisition history for the securities. Aggregate value (~$1.22M) is disclosed alongside an approximate sale date. Compared with the issuer's reported outstanding shares (54.8M), the proposed sale represents a small fraction of the float, suggesting limited direct dilution or market impact. Disclosure of prior sale by an insider adds context on recent insider activity. Missing header details reduce traceability in this extract.

Corporate Governance Expert

TL;DR: Compliance-focused filing shows insider liquidity actions; documentation is standard but some identifying fields are incomplete in the excerpt.

The notice meets Rule 144 structure by listing class, broker, share counts, acquisition dates, and payment types. Acquisition entries include exercised options, RSUs, and PSUs, which is helpful for assessing lock-up and vesting origins. The form includes the statutory certification about material nonpublic information. However, the provided content lacks certain filer identifier values, which hampers full governance review from this excerpt alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	61885	1223466.45	54797418	08/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/25/2022	Previously Exercised Options	Issuer			27000	05/25/2022	Cash
Common	12/01/2024	Restricted Stock Units	Issuer			15421	12/01/2024	N/A
Common	12/03/2024	Performance Stock Units	Issuer			19464	12/03/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
EDWARD M KAYE 45 Wiggins Ave Bedford MA 01730	Common	08/18/2025	12126	221153.99

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for STOK disclose about the proposed sale?

The form discloses a proposed sale of 61,885 common shares via Morgan Stanley Smith Barney with an aggregate market value of $1,223,466.45 and an approximate sale date of 08/29/2025.

How many shares outstanding does the filing report for STOK?

The filing reports 54,797,418 shares outstanding.

What is the acquisition history for the securities being sold?

Acquisitions listed are 27,000 shares from exercised options on 05/25/2022 (paid in cash), 15,421 RSUs on 12/01/2024, and 19,464 PSUs on 12/03/2024.

Did the filing disclose any recent sales by insiders?

Yes. It discloses that Edward M. Kaye sold 12,126 common shares on 08/18/2025 for $221,153.99.

Which broker is handling the proposed sale in the Form 144?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.